Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ulrik Lademann"'
Autor:
Mikkel Høeberg, Julie Boertmann Noer, Mette Vixø Vistesen, Annette Bartels, Esben Matzen Bech, Sune Boris Nygård, Ulrik Lademann, Jan Stenvang, Siqi Liu, Anja Thoe Fuglsang, Nils Brünner, José Manuel Afonso Moreira
Publikováno v:
Molecular Oncology, Vol 17, Iss 8, Pp 1595-1612 (2023)
Tissue inhibitor of metalloproteinases‐1 (TIMP‐1) regulates the proteolytic activity of matrix metalloproteinases (MMPs), playing an important role in the homeostasis of the extracellular matrix. Beyond its well‐known role in tissue maintenance
Externí odkaz:
https://doaj.org/article/514da4a7f4ac4728b3148bc37682ce11
The invariant chain CD74 protein is a cell surface binding partner of TIMP ‐1 in breast cancer cells
Autor:
Mikkel Høeberg, Julie Boertmann Noer, Mette Vixø Vistesen, Annette Bartels, Esben Matzen Bech, Sune Boris Nygård, Ulrik Lademann, Jan Stenvang, Siqi Liu, Anja Thoe Fuglsang, Nils Brünner, José Manuel Afonso Moreira
Publikováno v:
Molecular Oncology.
Autor:
Ulrik Ulrik Lademann, Jan Stenvang, Mikkel Høeberg, Anja T. Fuglsang, Nils Brünner, Mette V Vistesen, Maj Sofie Ørum-Madsen, Sune Boris Nygård, Lena Vinther Jensen, Siqi Liu, José M.A. Moreira, B. Viuff
Publikováno v:
Cancer Research. 75:P5-07
Tissue inhibitor of metalloproteinases 1 (Timp-1), is one of the four known endogenous inhibitors of matrix metalloproteinases (MMPs); in recent years, Timp-1 has become increasingly recognized as a multifunctional protein that, independently of its
Autor:
Vibeke Jensen, Anne-Sofie Schrohl, Nils Brünner, Xiaohong Deng, Jan Stenvang, Louise Fogh, Ulrik Lademann, Huanming Yang
Publikováno v:
Tumor Biology. 34:1161-1170
Tissue inhibitor of metalloproteinases-1 (TIMP-1) has been suggested as a marker of prognosis and response to treatment in breast cancer. In vitro, TIMP-1 can regulate shedding of the extracellular domain of HER2 and signalling via the Akt pathway, a
Autor:
Nicole Fehrenbacher, Maria Høyer-Hansen, Mikkel Rohde, Agnieszka Danielewicz, Ulrik Lademann, Marja Jäättelä, Mads Gyrd-Hansen, Jesper Nylandsted, Gabriele Multhoff, Ekkehard Weber
Publikováno v:
The Journal of Experimental Medicine
Heat shock protein 70 (Hsp70) is a potent survival protein whose depletion triggers massive caspase-independent tumor cell death. Here, we show that Hsp70 exerts its prosurvival function by inhibiting lysosomal membrane permeabilization. The cell dea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c3e0257a0879ef7716fb68e3c9beaa
https://doi.org/10.1084/jem.20040531
https://doi.org/10.1084/jem.20040531
Autor:
Ulrik Lademann, Maria Unni Rømer
Publikováno v:
Thrombosis and Haemostasis. 100:1041-1046
SummaryElevated levels of plasminogen activator inhibitor-1 (PAI-1) are associated with poor prognosis in cancer. An explanation to the elevated levels of PAI-1 could be a protective response to the increased proteolytic activity, caused by elevated
Autor:
Lars Holten-Andersen, S Beier Jensen, Ulrik Lademann, Birgitte Nauntofte, Peter Højrup, Jakob Harslund, Nils Brünner, Hans Jørgen Nielsen, Morten Thaysen-Andersen, Allan Bardow, P. Autzen Usher, Hanne Offenberg, Jesper Reibel
Publikováno v:
Holten-Andersen, L, Beier Jensen, S, Bardow, A, Harslund, J, Thaysen-Andersen, M, Lademann, U, Autzen Usher, P, Offenberg, H, Højrup, P, Reibel, J, Nielsen, H J, Brunner, N & Nauntofte, B 2008, ' Identifying sources and estimating glandular output of salivary TIMP-1 ', Scandinavian Journal of Clinical and Laboratory Investigation. Supplement, vol. 68, no. 7, pp. 548-554 . https://doi.org/10.1080/00365510701883180
Objective. Tissue inhibitor of metalloproteinases 1 (TIMP-1) has been identified as a potential biomarker in diseases such as cancer, cardiovascular diseases and diabetes. Since TIMP-1 resides in most tissues and bodily fluids, we evaluated the poten
Autor:
Kenneth Francis Hofland, Nils Brünner, Ib Jarle Christensen, Maria Unni Rømer, Ulrik Lademann, Peter Buhl Jensen, Lise Larsen
Publikováno v:
European Journal of Cancer. 41:1095-1100
Plasminogen activator inhibitor-1 (PAI-1) inhibits the activation of the plasminogen activator system, the latter being involved in cancer growth and dissemination. Interestingly, PAI-1 is elevated in many solid tumours and this elevation has consist
Autor:
Vibeke Jensen, Anne Sofie Schrohl, Ib Jarle Christensen, Ulrik Lademann, Sidse Ørnbjerg Würtz, Nils Brünner, Henning T. Mouridsen
Publikováno v:
Molecular & Cellular Proteomics. 4:483-491
Several studies have demonstrated an association between high tumor tissue levels of total tissue inhibitor of metalloproteinases-1 (TIMP-1) and a poor prognosis of primary breast cancer patients. In the present study we investigated whether measurem
Autor:
Kasper Almholt, Ole Lerberg Nielsen, Jørgen K. Larsen, Nils Brünner, Ulrik Lademann, Anne Kirkebjerg Due, Ib Jarle Christensen, Maria Unni Rømer, Kenneth Francis Hofland, P. Buhl-Jensen
Publikováno v:
Thrombosis and Haemostasis. 94:859-866
SummaryIn a number of cancer types high tumor tissue levels of plasminogen activator inhibitor type 1 (PAI-1) protein are strongly associated with shorter cancer patient survival. This association has been intriguing since PAI-1 is known to inhibit u